249 related articles for article (PubMed ID: 23328680)
21. Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal.
Singh G; Pai RS
Drug Deliv; 2016; 23(2):532-9. PubMed ID: 24963752
[TBL] [Abstract][Full Text] [Related]
22. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
23. Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier.
Jain AK; Khar RK; Ahmed FJ; Diwan PV
Eur J Pharm Biopharm; 2008 Jun; 69(2):426-35. PubMed ID: 18295464
[TBL] [Abstract][Full Text] [Related]
24. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
Giovino C; Ayensu I; Tetteh J; Boateng JS
Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
[TBL] [Abstract][Full Text] [Related]
26. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
27. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.
Damgé C; Maincent P; Ubrich N
J Control Release; 2007 Feb; 117(2):163-70. PubMed ID: 17141909
[TBL] [Abstract][Full Text] [Related]
28. Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.
Tran TH; Poudel BK; Marasini N; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Feb; 443(1-2):50-7. PubMed ID: 23318367
[TBL] [Abstract][Full Text] [Related]
29. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S
Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208
[TBL] [Abstract][Full Text] [Related]
30. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
31. Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine.
Wang T; Wang N; Song H; Xi X; Wang J; Hao A; Li T
Eur J Pharm Sci; 2011 Sep; 44(1-2):127-35. PubMed ID: 21742030
[TBL] [Abstract][Full Text] [Related]
32. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
Yin Y; Chen D; Qiao M; Lu Z; Hu H
J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180
[TBL] [Abstract][Full Text] [Related]
33. Insulin-loaded alginic acid nanoparticles for sublingual delivery.
Patil NH; Devarajan PV
Drug Deliv; 2016; 23(2):429-36. PubMed ID: 24901208
[TBL] [Abstract][Full Text] [Related]
34. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
Pawar H; Douroumis D; Boateng JS
Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
[TBL] [Abstract][Full Text] [Related]
35. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
[TBL] [Abstract][Full Text] [Related]
36. A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles.
Peng Q; Zhang ZR; Gong T; Chen GQ; Sun X
Biomaterials; 2012 Feb; 33(5):1583-8. PubMed ID: 22112760
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal Responsive Polymeric Nanoparticles for Oral Delivery of Insulin: Optimized Preparation, Characterization, and In Vivo Evaluation.
Fang Y; Wang Q; Lin X; Jin X; Yang D; Gao S; Wang X; Yang M; Shi K
J Pharm Sci; 2019 Sep; 108(9):2994-3002. PubMed ID: 31047941
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies.
Aksungur P; Demirbilek M; Denkbaş EB; Vandervoort J; Ludwig A; Unlü N
J Control Release; 2011 May; 151(3):286-94. PubMed ID: 21241752
[TBL] [Abstract][Full Text] [Related]
39. Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques.
Elvassore N; Bertucco A; Caliceti P
J Pharm Sci; 2001 Oct; 90(10):1628-36. PubMed ID: 11745721
[TBL] [Abstract][Full Text] [Related]
40. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
